We observed that the number of CD44+CD133+ cells was increased by the autophagy inducer rapamycin but was decreased by the autophagy inhibitor CQ or knockdown of autophagy-related genes, revealing the requirement of autophagy for the maintenance of CD44+CD133+ cells in pancreatic cancer. The gene discussed is PROM1; the disease is familial pancreatic carcinoma.